An international study led by Monash University has done what could be the world's first demonstration of an AI model that can predict the optimal anti-seizure medication for newly diagnosed epilepsy patients. The research team has trained a deep-learning prediction model using clinical information from around 1,800 patients in five health care centres in Australia, Malaysia, China and the United Kingdom. The model is designed by the Monash Medical AI Group and is trained using Monash's MASSIVE computing facility. Findings from the study, which was published in the journal JAMA Neurology, showed that the AI model has a "modest" 65% accuracy in predicting the best anti-seizure medication. The research team is still improving the model by employing more complex information.